Showing results (1101-1110 of 4,010) with videos related to

Sort By:
Pageof 401
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 17, 2021
The Testamentary Capacity Assessment Tool (TCAT): validation and normative dataNadia Bolognini, Chiara Gramegna, Antonella Esposito, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|January 12, 2016
Rapid Maxillary Expansion After Alveolar Bone Grafting With rhBMP-2 in UCLP Evaluated by Means of CBCTDaniela Garib, Felicia Miranda, Renata Sathler, et al.
Journal of Clinical & Laboratory Immunology|August 1, 1989
The role of arachidonic acid metabolite PGE2 on T cell proliferative responseS Valitutti, F Castellino, F B Aiello, et al.
Molecules (Basel, Switzerland)|July 27, 2022
Mass Spectrometry-Based Peptide Profiling of Haemolymph from Pterostichus melas Exposed to Pendimethalin HerbicideDonatella Aiello, Anita Giglio, Federica Talarico, et al.
Sensors (Basel, Switzerland)|March 26, 2022
An Innovative Malaxer Equipped with SCADA Platform for Improving Extra Virgin Olive Oil QualityMariangela Vallone, Giuseppe Aiello, Filippa Bono, et al.
Investigative Ophthalmology & Visual Science|October 1, 1996
Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cellsH Takagi, G L King, G S Robinson, et al.
Clinical Journal of Oncology Nursing|December 2, 2009
Putting evidence into practice: what are the pharmacologic interventions for nociceptive and neuropathic cancer pain in adults?Lisa Aiello-Laws, Janice Reynolds, Nancy Deizer, et al.
British Journal of Pharmacology|January 1, 1992
Role of muscarinic receptor subtypes in central antinociceptionA Bartolini, C Ghelardini, L Fantetti, et al.
American Journal of Epidemiology|September 18, 2007
Socioeconomic gradients in immune response to latent infectionJennifer Beam Dowd, Mary N Haan, Lynn Blythe, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2021
FFAR1/GPR40: One target, different binding sites, many agonists, no drugs, but a continuous and unprofitable tug-of-war between ligand lipophilicity, activity, and toxicityPaolo Governa, Maria Cristina Caroleo, Gabriele Carullo, et al.
Pageof 401